Drug intelligence / Profile preview

autologous intrathecal hematopoietic stem cells

Development stage: Unknown
Lead developer: Hospital Universitario, Dr. José
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intrathecal

Overview

This autologous cell therapy is being developed by Hospital Universitario Dr. Jose E. Gonzalez (Universidad Autónoma de Nuevo León) for the treatment of autism spectrum disorder (ASD). The therapy involves harvesting bone marrow from the patient, isolating CD34+ hematopoietic stem cells from the mononuclear cell fraction, and administering them intrathecally into the cerebrospinal fluid. The treatment leverages the immunomodulatory properties and neuroplastic potential of these stem cells to address neurodevelopmental deficits and improve neurologic and social skills in pediatric patients. It is currently being evaluated in a Phase 3 clinical trial (NCT01740869) to assess its efficacy compared to observation.

Other names: Autologous Bone Marrow Stem Cellsautologous CD34+ hematopoietic stem cellsbone marrow-derived mononuclear cellsBM-MNC

Beyond the preview

Go deeper on autologous intrathecal hematopoietic stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous intrathecal hematopoietic stem cells.

Explore the full profile